Skip Nav Destination
Close Modal
Search Results for
dexamethasone
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Book Series
Date
Availability
1-20 of 1053 Search Results for
dexamethasone
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Book Chapter
Series: Developments in Ophthalmology
Volume: 55
Published: 27 October 2015
10.1159/000431198
EISBN: 978-3-318-05565-8
... dexamethasone, triamcinolone and fluocinolone. During the past few years, new drug delivery methods for corticosteroids have been developed and are now part of our therapeutic armamentarium. This chapter provides a brief description of the pharmacology, efficacy and adverse effects associated with the use...
Book Chapter
Series: Endocrine Development
Volume: 20
Published: 17 December 2010
10.1159/000321228
EISBN: 978-3-8055-9644-2
... Abstract Prenatal treatment of congenital adrenal hyperplasia (CAH) with dexamethasone (DEX) has been in use since the mid- 1980s. Its effectiveness for reducing virilization of external genitalia is well established. DEX treatment has to be started in the 6th–7th postmenstrual week...
Book Chapter
Series: Contributions to Oncology
Volume: 49
Published: 21 July 1995
10.1159/000424069
EISBN: 978-3-318-03432-5
Book Chapter
Book: Bacterial Meningitis
Series: Antibiotics and Chemotherapy
Volume: 45
Published: 27 March 1992
10.1159/000421007
EISBN: 978-3-318-03220-8
Book Chapter
Published: 06 March 1992
10.1159/000420891
EISBN: 978-3-318-04728-8
Book Chapter
Series: Progress in Respiratory Research
Volume: 25
Published: 05 January 1990
10.1159/000417826
EISBN: 978-3-318-04128-6
Book Chapter
Book: Depressive Illness: Biological and Psychopharmacological Issues Symposium, Amsterdam, September 1980
Series: Advances in Biological Psychiatry
Volume: 7
Published: 15 December 1981
10.1159/000400206
EISBN: 978-3-318-03056-3
Book Chapter
Book: Clinical Importance of Surfactant Defects: International Symposium, Hamburg, October-November 1979
Series: Progress in Respiratory Research
Volume: 15
Published: 09 January 1981
10.1159/000390649
EISBN: 978-3-318-04118-7
Book Chapter
Series: Advances in Biological Psychiatry
Volume: 5
Published: 01 October 1980
10.1159/000387415
EISBN: 978-3-318-03054-9
Book Chapter
Published: 23 July 1976
10.1159/000398043
EISBN: 978-3-318-04294-8
Book Chapter
Series: Current Studies in Hematology and Blood Transfusion
Volume: 43
Published: 31 May 1976
10.1159/000399197
EISBN: 978-3-318-03513-1
Book Chapter
Published: 13 October 1971
10.1159/000392215
EISBN: 978-3-318-04784-4
Book Chapter
Published: 04 September 1967
10.1159/000389401
EISBN: 978-3-318-04722-6
Book Chapter
Volume: 18
Published: 31 December 1961
10.1159/000229166
EISBN: 978-3-318-06238-0
Book Chapter
Volume: 18
Published: 31 December 1961
10.1159/000229173
EISBN: 978-3-318-06238-0
Book Chapter
Published: 24 November 1981
10.1159/000396164
EISBN: 978-3-318-04807-0
Book Chapter
Published: 14 June 1985
10.1159/000411562
EISBN: 978-3-318-04632-8
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459691
EISBN: 978-3-318-06042-3
... corticosteroid options for DME treatment are available: the dexamethasone delivery system, the fluocinolone acetonide insert, and off-label intravitreal triamcinolone acetonide. All 3 agents are associated with risk of cataract progression and intraocular pressure elevation, but they maintain a good safety...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
EISBN: 978-3-318-06042-3
..., et al: Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 2011;52:80-86. 26. Kuppermann BD, Blumenkranz MS, Haller JA, et al; Dexamethasone DDS Phase II Study Group: Randomized controlled study of an intravitreous...
Book Chapter
Series: Developments in Ophthalmology
Volume: 55
Published: 27 October 2015
EISBN: 978-3-318-05565-8
...References References 1. Weijtens O, Schoemaker RC, Romijn FP, et al: Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology 2002;109:1887-1891. 2. Weijtens O, Feron EJ, Schoemaker RC, et al: High concentration...
1